SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-17-021601
Filing Date
2017-11-06
Accepted
2017-11-03 21:26:23
Documents
2
Period of Report
2017-11-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K insy-8k_20171102.htm 8-K 38069
2 EX-99.1 insy-ex991_6.htm EX-99.1 77429
  Complete submission text file 0001564590-17-021601.txt   116636
Mailing Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044
Business Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044 602-910-2617
Insys Therapeutics, Inc. (Filer) CIK: 0001516479 (see all company filings)

IRS No.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35902 | Film No.: 171178077
SIC: 2834 Pharmaceutical Preparations